Comparative efficacy and safety of biologics and systemic immunomodulatory treatments for chronic urticaria: Systematic review and network meta-analysis.
Chu AWL, Oykhman P, Chu X, Rayner DG, Bhangal S, Dam A, Xu J, Sheikh J, Trayes KP, Frazier WT, Lang DM, Beck LA, Mathur SK, Waserman S, Thabane L, Asiniwasis RN, Runyon L, Moellman J, Oliver ET, Chan J, Cole EF, Baker DR, Khan DA, Ben-Shoshan M, Wheeler KE, Eftekhari S, Gardner DD, Winders T, Flindall M, Tattrie J, Bernstein JA, Saini SS, Chu DK.
Chu AWL, et al.
J Allergy Clin Immunol. 2025 Oct;156(4):1008-1023. doi: 10.1016/j.jaci.2025.06.004. Epub 2025 Jul 15.
J Allergy Clin Immunol. 2025.
PMID: 40663028
Free article.
BACKGROUND: Chronic urticaria is a common skin condition characterized by itchy wheals (hives), angioedema, or both, lasting for 6 weeks or more. Beyond antihistamines, multiple systemic treatments are available, but there is uncertainty regarding their comparative …
BACKGROUND: Chronic urticaria is a common skin condition characterized by itchy wheals (hives), angioedema, or both, lasting f …